ProfileGDS4284 / 214600_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 10% 25% 17% 32% 33% 34% 29% 23% 33% 30% 6% 32% 28% 5% 36% 40% 37% 37% 15% 34% 30% 20% 2% 19% 34% 35% 15% 29% 23% 0% 23% 25% 37% 25% 30% 4% 23% 19% 24% 22% 16% 22% 20% 12% 26% 30% 25% 1% 54% 27% 24% 35% 29% 37% 8% 11% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control14.79610
GSM687648Patient 402 control54.66925
GSM687653Patient 403 control29.739117
GSM687658Patient 404 control91.026832
GSM687663Patient 411 control100.79533
GSM687668Patient 422 control96.184834
GSM687673Patient 424 control81.102729
GSM687678Patient 425 control54.260123
GSM687683Patient 427 control101.89533
GSM687688Patient 428 control77.539130
GSM687695Patient 441 control22.44526
GSM687699Patient 443 control107.39832
GSM687704Patient 444 control70.549928
GSM687707Patient 448 control13.14495
GSM687712Patient 449 control111.97736
GSM687719Patient 450 control160.53240
GSM687724Patient 451 control130.57937
GSM687728Patient 452 control128.03437
GSM687646Patient 401 treated 24h25.843115
GSM687649Patient 402 treated 24h87.20634
GSM687665Patient 411 treated 24h87.905330
GSM687651Patient 402 treated 4 weeks42.811520
GSM687667Patient 411 treated 4 weeks6.488012
GSM687670Patient 422 treated 24h37.945119
GSM687671Patient 422 treated 4 weeks91.278234
GSM687654Patient 403 treated 24h93.681535
GSM687675Patient 424 treated 24h31.534515
GSM687685Patient 427 treated 24h74.118429
GSM687656Patient 403 treated 4 weeks44.033523
GSM687677Patient 424 treated 4 weeks2.040160
GSM687687Patient 427 treated 4 weeks43.95223
GSM687692Patient 428 treated 4h58.947625
GSM687716Patient 449 treated 4h114.39737
GSM687722Patient 450 treated 4h70.4125
GSM687680Patient 425 treated 24h80.324430
GSM687690Patient 428 treated 24h8.2764
GSM687700Patient 443 treated 24h77.865823
GSM687705Patient 444 treated 24h34.396519
GSM687714Patient 449 treated 24h48.880124
GSM687721Patient 450 treated 24h56.453322
GSM687682Patient 425 treated 4 weeks25.992916
GSM687694Patient 428 treated 4 weeks41.358722
GSM687702Patient 443 treated 4 weeks43.643220
GSM687718Patient 449 treated 4 weeks22.357112
GSM687723Patient 450 treated 4 weeks66.40126
GSM687661Patient 404 treated 4h82.785730
GSM687710Patient 448 treated 4h58.093425
GSM687726Patient 451 treated 4h3.882841
GSM687730Patient 452 treated 4h470.29954
GSM687660Patient 404 treated 24h87.209227
GSM687697Patient 441 treated 24h75.960424
GSM687709Patient 448 treated 24h117.70535
GSM687725Patient 451 treated 24h92.622629
GSM687729Patient 452 treated 24h161.21637
GSM687727Patient 451 treated 4 weeks18.30698
GSM687731Patient 452 treated 4 weeks21.855611